A detailed history of Farther Finance Advisors, LLC transactions in Cerus Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 725 shares of CERS stock, worth $1,116. This represents 0.0% of its overall portfolio holdings.

Number of Shares
725
Previous 725 -0.0%
Holding current value
$1,116
Previous $1.25 Million 1.2%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$1.66 - $2.42 $21 - $31
-13 Reduced 1.76%
725 $1.31 Million
Q4 2023

Feb 14, 2024

BUY
$1.25 - $2.35 $922 - $1,734
738 New
738 $1.59 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $273M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.